全文获取类型
收费全文 | 27828篇 |
免费 | 3764篇 |
国内免费 | 719篇 |
专业分类
耳鼻咽喉 | 435篇 |
儿科学 | 749篇 |
妇产科学 | 372篇 |
基础医学 | 1872篇 |
口腔科学 | 1745篇 |
临床医学 | 1528篇 |
内科学 | 4135篇 |
皮肤病学 | 309篇 |
神经病学 | 889篇 |
特种医学 | 783篇 |
外国民族医学 | 18篇 |
外科学 | 8427篇 |
综合类 | 2345篇 |
现状与发展 | 5篇 |
预防医学 | 1063篇 |
眼科学 | 411篇 |
药学 | 761篇 |
8篇 | |
中国医学 | 250篇 |
肿瘤学 | 6206篇 |
出版年
2024年 | 13篇 |
2023年 | 716篇 |
2022年 | 687篇 |
2021年 | 1429篇 |
2020年 | 1511篇 |
2019年 | 1550篇 |
2018年 | 1493篇 |
2017年 | 1366篇 |
2016年 | 1285篇 |
2015年 | 1424篇 |
2014年 | 2110篇 |
2013年 | 2113篇 |
2012年 | 1456篇 |
2011年 | 1577篇 |
2010年 | 1158篇 |
2009年 | 1230篇 |
2008年 | 1370篇 |
2007年 | 1217篇 |
2006年 | 1095篇 |
2005年 | 1005篇 |
2004年 | 926篇 |
2003年 | 797篇 |
2002年 | 647篇 |
2001年 | 545篇 |
2000年 | 446篇 |
1999年 | 402篇 |
1998年 | 345篇 |
1997年 | 298篇 |
1996年 | 237篇 |
1995年 | 217篇 |
1994年 | 216篇 |
1993年 | 153篇 |
1992年 | 164篇 |
1991年 | 147篇 |
1990年 | 121篇 |
1989年 | 109篇 |
1988年 | 99篇 |
1987年 | 79篇 |
1986年 | 82篇 |
1985年 | 77篇 |
1984年 | 67篇 |
1983年 | 49篇 |
1982年 | 56篇 |
1981年 | 46篇 |
1980年 | 49篇 |
1979年 | 38篇 |
1978年 | 32篇 |
1977年 | 19篇 |
1976年 | 19篇 |
1975年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
31.
BackgroundLymph node recurrences (LNR) from colorectal cancer (CRC) still represent a therapeutic challenge, as standardized recommendations have yet to be established. The aim of this study was to analyze short- and long-term oncological outcomes following resection of LNR from CRC.MethodsAll patients with previously resected CRC who underwent histopathologically confirmed LNR resection in 3 tertiary referral centers between 2010 and 2017 were reviewed. Short- and long-term outcomes were analyzed, mainly recurrence-free and overall survival. Further recurrences following LNR resection were also analyzed.ResultsOverall, 18 patients were included. Primary CRC was left-sided in 16 (89%) patients, staged T3-4 in 15 (83%), N+ in 14 (78%) and presented with synchronous metastases in 8 (43%). Median time interval between primary CRC and LNR resections was 31 months. Performed lymphadenectomies were aortocaval (n = 10), pelvic (n = 7), in hepatic pedicle (n = 3) and mesenteric (n = 1). Four patients had associated liver metastases resection. Three (17%) presented with postoperative complications, of which one Clavien-Dindo 3. Fourteen (78%) patients presented with further recurrences after a mean delay of 9 months, with 36% of patients presenting with early (<6 months) recurrence. Five (36%) patients could undergo secondary recurrence resection and 3 (21%) patients radiotherapy. Median overall survival following LNR resection reached 44 months.ConclusionsCurrent results suggest that LNR resection is feasible and associated with improved survival, in selected patients. Longer time interval between primary CRC resection and LNR occurrence appeared to be a favorable prognostic factor whereas multisite recurrence appeared to be associated with impaired long-term survival. 相似文献
32.
Ioana A Campean 《Expert opinion on pharmacotherapy》2020,21(10):1193-1200
ABSTRACT
Introduction
Despite an increasingly older pulmonary hypertension (PH) population, data on PH treatments in these patients are limited because there exist no clinical studies dedicated to geriatric groups. Furthermore, elderly patients with comorbidities have been systematically excluded from clinical trials, limiting the evidence base for drugs approved for pulmonary arterial hypertension (PAH). 相似文献33.
目的:探讨食管鳞癌患者远处转移部位与预后的相关性及生存分析。方法:从SEER数据库中提取2010年至2015年共439例食管鳞癌伴远处转移患者的临床资料,回顾性分析比较食管鳞癌远处转移部位与预后的相关性,通过χ2检验比较两组变量的差异,采用Kaplan-Meier法绘制生存曲线,Log-rank检验进行单因素分析,COX回归进行多因素分析。结果:肺转移、骨+肺转移、肝+肺转移患者预后较好;骨转移、脑转移、骨+脑转移、骨+脑+肝+肺转移患者预后较差。单因素分析显示:年龄、原发灶部位、T分期、手术情况、多器官转移情况与食管鳞癌远处转移患者的预后有关(P<0.05);多因素分析显示:年龄、手术情况与多器官转移情况是影响食管鳞癌远处转移患者总生存时间(OS)的独立危险因素。结论:食管鳞癌伴远处转移的患者整体预后较差,但年龄在60~69岁区间、接受手术治疗与较好的预后相关。仅单器官转移的食管鳞癌患者中,骨转移、脑转移患者预后较差;合并多器官转移的患者中,骨+脑转移、骨+脑+肝+肺转移患者预后较差。 相似文献
34.
《Clinical genitourinary cancer》2020,18(5):e531-e542
BackgroundPrimary management of localized, intermediate-risk prostate cancer consists of radical prostatectomy (RP), radiotherapy (RT) with short-course androgen deprivation therapy (ADT), or RT alone. The purpose of this study was to determine if these treatment strategies have equivalent overall survival (OS) in patients < 55 years old with intermediate-risk prostate cancer.Patients and MethodsWe identified 35,134 patients in the National Cancer Data Base with localized intermediate-risk prostate cancer treated with RP, RT + ADT, or RT from 2004 to 2013. Ten-year OS rates were estimated by the Kaplan-Meier method. Adjusted hazard ratios (HR) with 95% confidence intervals (CI) were computed by multivariate Cox regression.ResultsA total of 29,920 patients (85.2%) underwent RP, 1393 (4.0%) RT + ADT, and 3821 (10.9%) RT. Median patient age was 51 years old, and median follow-up was 59.9 months. Ten-year OS was estimated to be 94.2% for RP, 80.7% for RT + ADT, and 85.2% for RT (P < .0001). On multivariate analysis, treatment with RT + ADT or RT was associated with significantly worse OS compared to treatment with RP (RT + ADT HR = 2.06, 95% CI 1.67-2.54, P < .0001; RT HR = 2.0, 95% CI 1.71-2.33, P < .0001). Patients who met all 3 of the intermediate-risk criteria showed worse OS compared to patients who met only one criterion (HR = 1.80; 95% CI, 1.32-2.44; P = .0002).ConclusionRP is significantly more likely than RT + ADT or RT to be used as a primary treatment for young men with localized intermediate prostate cancer. RP was also associated with improved OS compared to RT + ADT and RT. 相似文献
35.
36.
37.
Syed Khizer Hasan Nikhil V. Patkar Deepan Rajamanickam Anant Gokarn Antonio R. Lucena-Araujo Prashant Tembhare Bhausaheb Bagal Pratibha Kadam Amare Hasmukh Jain Sumeet Gujral Manju Sengar Papagudi Ganesan Subramanian Navin Khattry 《Hematological oncology》2020,38(5):808-816
The high expression of brain and acute leukemia, cytoplasmic (BAALC) and ETS-related gene (ERG) has been reported to influence the outcome in acute myeloid leukemia (AML), but due to limited prospective studies, their role as prognostic factors is unclear. At diagnosis, the prognostic value of BAALC and ERG expression with respect to other cytogenetic and molecular markers was analyzed in 149 AML patients. Patients were divided into quartiles which resulted in the formation of four groups (G1–G4) based on expression values of BAALC and ERG and clinical response defined across groups. Groups with similar survival probabilities were merged together and categorized subsequently as high versus low expressers. Patients with high BAALC and ERG expression had significantly lower overall survival (OS; BAALC: p = 0.001 at 5 years 29.4% vs. 69.8%; ERG: p < 0.0001 at 5 years 4% vs. 50.4%) and disease-free survival (BAALC: p = 0.001 at 5 years 19.5% vs. 69.8%; ERG: p < 0.0001 at 5 years 4.2% vs. 47%). Patients were further stratified combining BAALC and ERG expression in an integrative prognostic risk score (IPRS). After a median follow-up of 54 months (95% CI 45–63 months) among survivors, IPRS for high versus low expressers was a significant predictor for OS (BAALC + ERG: 4% vs. 71.6%, p < 0.0001) and DFS (BAALC + ERG: 4.5% vs. 74.1%, p < 0.0001). In a multivariate model, IPRS of BAALC + ERG expression retained prognostic significance for OS (hazard ratio [HR] 2.96, 95%CI 1.91–4.59, p < 0.001) and DFS (HR 3.61, 95%CI 2.26–5.76, p < 0.001). 相似文献
38.
39.
《International journal of oral and maxillofacial surgery》2019,48(9):1163-1168
Free microsurgical tissue transfer of the latissimus dorsi flap may be indicated for the restoration of intra- and extraoral defects, especially when a large-sized skin island flap is required. In many cases, use of the latissimus dorsi flap for coverage of large-sized intraoral defects results in bulkiness due to the proportion of subcutaneous fat. Prelamination of free flaps appears to be a promising technique to overcome this flap bulkiness. This modification in flap design could improve the postoperative functional outcome, as well as reduce donor site morbidity. This article presents four novel clinical cases, in which the patients underwent prelamination of the latissimus dorsi flap with local skin grafts during oral cancer treatment in order to reduce the thickness of the free flap and allow tension-free primary closure of the donor site. These attempts successfully covered large-sized intraoral defects, achieving good functional outcomes with minimal donor site morbidity. 相似文献
40.